相关实验视频
Updated: May 15, 2025

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
35.7K
非编码RNAs作为乳腺癌上皮质-介质酶过渡的关键调节者
Jing Peng1, Wenhui Liu1, Jiaju Tian1
1The First Clinical Medical College, Lanzhou University, Lanzhou, China.
Frontiers in cell and developmental biology
|April 9, 2025
概括
非编码RNAs (ncRNAs) 在乳腺癌转移中关键调节上皮细胞-介质细胞过渡 (EMT). 了解ncRNA的作用为这种恶性瘤提供了新的诊断和治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 皮质-介质细胞过渡 (EMT) 对于乳腺癌转移至关重要.
- 非编码RNAs (ncRNAs),包括miRNAs,lncRNAs和circRNAs,是细胞过程的关键调节者.
- 对ncRNAs的失调与包括乳腺癌在内的各种癌症有关.
研究的目的:
- 审查ncRNAs在乳腺癌中调节EMT中的作用.
- 探索ncRNAs在乳腺癌转移中的诊断和治疗潜力.
- 巩固最近关于ncRNA介导的EMT调节的发现.
主要方法:
- 关于乳腺癌中ncRNAs和EMT的最新研究的文献综述.
- 分析不同类型的ncRNAs (miRNAs, lncRNAs, circRNAs) 调节EMT的机制.
- 检查ncRNAs对癌细胞迁移,入侵和治疗耐药性的影响.
主要成果:
- ncRNAs通过调节基因表达和信号通路显著影响EMT.
- 微RNAs (miRNAs) 通常会抑制与EMT相关的转录因子.
- 长非编码RNAs (lncRNAs) 和圆形RNAs (circRNAs) 与miRNAs相互作用,影响EMT的进展.
- ncRNAs在乳腺癌转移和治疗耐药性方面发挥着作用.
结论:
- ncRNAs是EMT和乳腺癌转移的关键调节者.
- 基于ncRNA的生物标志物有望改善乳腺癌诊断.
- 向ncRNAs是对抗乳腺癌转移和耐药性的潜在治疗策略.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
Regulation of Expression at Multiple Steps
849
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
849
Epigenetic Regulation
30.8K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.8K

